Montgomery Rice Buys Shares of UnitedHealth Group

Montgomery Rice, an insider at UnitedHealth Group Incorporated, bought 41 shares of the company on June 23, 2026. This recent insider purchase comes as the stock traded near $415.53 on Friday.

What Changed in Montgomery Rice's UnitedHealth Group Position

Montgomery Rice's acquisition of 41 shares is part of continued insider activity in UnitedHealth Group. The purchase did not involve a planned transaction and was not part of a broader trend of insider buying or selling.

Other Institutional Activity in UnitedHealth Group

Many institutional investors have been active in UnitedHealth Group. BlackRock, Inc. reduced its holdings by 1,276,021 shares, ending with 73,467,531 shares worth about $19.9 billion, marking a 1.7% decrease. Vanguard Capital Management LLC opened a new position with 58,870,777 shares valued at approximately $15.9 billion. State Street Corp increased its stake by 100,016 shares, bringing its total to 45,332,186 shares valued at $12.3 billion, a modest 0.2% increase. Capital World Investors added 5,192,373 shares, a 23% increase, resulting in 27,783,415 shares worth about $7.5 billion. Geode Capital Management, LLC increased its position by 977,105 shares, ending with 22,768,695 shares valued at $6.1 billion, a 4.5% increase.

UnitedHealth Group Incorporated Stock Up 5.7%

Shares of NYSE:UNH traded near $415.53 on Friday. UnitedHealth Group has a market cap of $369.3 billion, a P/E ratio of 30.6, and a forward P/E of 19.4. The stock has a 52-week low of $234.60 and a high of $415.98. Its 50-day moving average stands at $372.67, while the 200-day moving average is $333.55. The company has a current ratio of 0.798 and a quick ratio of 0.722, with a debt-to-equity ratio of 73.98.

Recent Earnings

UnitedHealth Group reported revenue of $449.7 billion, reflecting a 2% growth. Its net margin was 2.68%, and the return on equity stood at 12.18%. The company is set to announce its next earnings on July 16, 2026.

Dividend

UnitedHealth Group offers an annual dividend rate of $9.28, yielding 2.31%. The dividend payout ratio is 66.57%.

Insider Buying and Selling at UnitedHealth Group Incorporated

On June 23, several insiders made purchases. Frederick William McNabb III bought 50 shares, Paul Garcia and Charles Baker each bought 13 shares, and Christopher Zaetta, EVP & Chief Legal Officer, acquired 61 shares. Timothy Patrick Flynn also purchased 61 shares, while CEO Stephen Hemsley acquired 46 shares. None of these transactions were planned.

Analysts Set New Price Targets

Analysts continue to show confidence in UnitedHealth Group. On June 24, 2026, B of A Securities maintained a buy rating with a $475 target. Leerink Partners, on June 17, also maintained a buy rating with a $462 target. Other firms like Mizuho and JP Morgan maintained buy ratings with targets of $460 and $466, respectively. The consensus among 26 analysts is a buy rating, with a mean target price of $409.77.

About UnitedHealth Group

UnitedHealth Group Incorporated, based in Eden Prairie, Minnesota, operates as a major healthcare company. It provides health benefit plans and services through its UnitedHealthcare segment, and health services through its Optum segments, including Optum Health, Optum Insight, and Optum Rx. The company serves a wide range of customers, including employers, governments, and individuals, with a workforce of about 390,000 employees.

Bottom Line

The insider purchase by Montgomery Rice is part of broader insider activity at UnitedHealth Group, a company with significant institutional interest. With a strong market cap and consistent analyst support, UnitedHealth Group remains a key player in the healthcare sector. Investors should note that insider transactions like these are reported after they occur and may not reflect current activity.